1. Home
  2. DTI vs IMA Comparison

DTI vs IMA Comparison

Compare DTI & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$2.31

Market Cap

68.0M

Sector

Industrials

ML Signal

HOLD

IMA

ImageneBio Inc.

N/A

Current Price

$5.59

Market Cap

66.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTI
IMA
Founded
1984
2019
Country
United States
United States
Employees
N/A
17
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.0M
66.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DTI
IMA
Price
$2.31
$5.59
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$16.00
AVG Volume (30 Days)
315.1K
8.4K
Earning Date
05-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$154,446,000.00
N/A
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.65
$3.94
52 Week High
$4.69
$17.50

Technical Indicators

Market Signals
Indicator
DTI
IMA
Relative Strength Index (RSI) 52.20 43.53
Support Level $2.29 $5.36
Resistance Level $2.34 $6.13
Average True Range (ATR) 0.08 0.31
MACD 0.04 -0.04
Stochastic Oscillator 88.71 22.45

Price Performance

Historical Comparison
DTI
IMA

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About IMA ImageneBio Inc.

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Share on Social Networks: